Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (31)
NITAG documentation (1591)
Reports (55)
SAGE documentation (222)
Scientific publications (112)
Systematic reviews (SYSVAC) (2853)
Regions
Africa (274)
Americas (766)
Eastern Mediterranean (50)
Europe (705)
South-East Asia (81)
Western Pacific (199)
Diseases
Chikungunya (9)
Cholera (34)
COVID-19 (1513)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (80)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (68)
Hepatitis A (64)
Hepatitis B (157)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (68)
HIV / AIDS (10)
Human papillomavirus (HPV) (493)
Influenza (581)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (28)
Measles (130)
Meningococcal disease (148)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (46)
Pertussis (105)
Pneumococcal disease (277)
Poliomyelitis (86)
Q fever (1)
Rabies (29)
Rotavirus (117)
RSV (Respiratory syncytial virus) (48)
Rubella (64)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (60)
Tick-borne encephalitis (12)
Tuberculosis (77)
Typhoid (24)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4864 results found
2022
∙
NACI
Recombinant influenza vaccines: A supplemental statement of the Canadian Immunization Guide chapter on influenza and statement on seasonal influenza vaccine for 2022–2023
2022
∙
NACI
Recommendations on the use of bivalent Omicroncontaining mRNA COVID-19 vaccines
2022
∙
ATAGI
ATAGI clinical guidance on vaccination against Monkeypox
2022
∙
Conseil Supérieur de la Santé (CSS)
Belgium Vaccination strategy against Monkeypox (revision, August 2022)
2022
∙
Moses C. Simuyemba, Chitalu Chama-Chiliba, Abson Chompola, Aaron Sinyangwe, Abdallah Bchir, Gilbert Asiimwe, Felix Masiye
Evaluating the functionality and effectiveness of ZITAG and related expanded programme on immunisation technical committees in Zambia
2022
∙
SAGE
Interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
2022
∙
JCVI
JCVI statement on a one-dose schedule for the routine HPV immunisation programme
2022
∙
NIAC
NIAC Recommendations for additional COVID-19 Booster Vaccination
2022
∙
ATAGI
Novavax vaccine for adolescents aged 12-17 years
2022
∙
NACI
Process for incorporating economic evidence into federal vaccine recommendations: National Advisory Committee on Immunization (NACI)
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register